Pharma Solutions
We offer proprietary biomarkers focused on the identification and monitoring of disease in clinical trials, delivered as a turn-key medical imaging solution via a secure, cloud-based software as a service (SaaS).
300+
Sites globally
30+
Clinical trials as an imaging provider
60,000+
Scans delivered
100,000
Individuals' imaging data will be managed as part of the UK Biobank - the world's largest multi-site imaging study acquired over 5 years
De-risk Trial Design & Reduce Timeline to Approval
Quantitative, non-invasive image analysis services for improved decision-making and accelerated drug development that is flexible and scalable to all phases of clinical trials.
Non-invasive
patient stratification
Speed-up enrolment
and reduce drop-out
Early efficacy
/ safety indication
Lower
screen fail rate
Long term
patient monitoring
Enhance trial
enrichment
Therapeutic Areas
End-to-end study management and protocol consulting services for clinical studies in liver disease — including metabolic, autoimmune and cholestatic — cancer, diabetes, cardiac, and IBD.
Medical Imaging Services
Quantitative, non-invasive image analysis services for improved decision-making and accelerated drug development that are flexible and scalable to all phases of clinical trials.
Liver
Liver Fat
Fibroinflammation
Iron Load
Volume
Liver Stiffness
Biliary System Metrics
Spleen
Fibrosis
Volume
Portal Hypertension
Pancreas
Fibrosis
Pancreatic Fat
Volume
Pancreatic Duct Metrics
Kidneys
Fibrosis
Diffusion
Blood Oxygenation
Volume
Cortex Metrics
Medulla Metrics
Heart
LV Function
RV Function
LV Mass
LV Wall Thickness
Diastolic Function
Aorta
Distensibility
Diameter
Wall Thickness
Pulse Wave Velocity
Colon
Endoscopy
Digital Pathology
MR Enterography
Lungs
Regular Breathing Rate
Inspiration Volume
Expiration Volume
Ejection Fraction
Body Composition
Visceral Adipose Tissue (VAT)
Subcutaneous Adipose Tissue (SAT)
Lean Muscle Mass
Muscle Fat Infiltration (MFI)
DEXA
Multi-Organ Characterisation
Comprehensive Patient Health
Expert central reads of quantitative metrics for:
Liver, kidneys, pancreas, spleen, heart, aorta, biliary tree, colon, body composition, and bone mineral density
Imaging Technologies include:
MRI, computerised tomography (CT) scans, positron emission tomography (PET) scans, DXA, endoscopy, and digital pathology.
Global Imaging Centre Network
We’ve formed a 300+ site smart imaging network, focused on driving the integration of quantitative imaging in clinical research, improving imaging data quality, streamlining logistics, and reducing the cost of imaging in clinical trials.
Central Imaging Service
We receive raw images acquired by our trained imaging centers and analyse them using proprietary artificial intelligence and machine learning algorithms.
All images are checked for quality, and every report undergoes a review process prior to return. Our Perspectum Portal performs a single platform for access to data and results.
Learn more